Aurora Spine

ASG-X

Analysis and Opinions about ASG-X

Signal
Opinion
Expert
WATCH
WATCH
June 9, 2016

It was all " gung ho" about 2 years ago. It is difficult to find out what is going on. Management have been rather shy for a long time. Overall revenues have not risen dramatically for a long time. There are a lot of competitors. He needs to look more closely into the company.

Aurora Spine (ASG-X)
June 9, 2016

It was all " gung ho" about 2 years ago. It is difficult to find out what is going on. Management have been rather shy for a long time. Overall revenues have not risen dramatically for a long time. There are a lot of competitors. He needs to look more closely into the company.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$0.205
Owned
Unknown
HOLD
HOLD
September 15, 2015

It was really unfortunate in that it came out at the peak of interest in the small medical field related companies, and is competing with 12-13 others. It probably will get taken out.

Aurora Spine (ASG-X)
September 15, 2015

It was really unfortunate in that it came out at the peak of interest in the small medical field related companies, and is competing with 12-13 others. It probably will get taken out.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$0.320
Owned
Yes
COMMENT
COMMENT
June 30, 2015

One of the most disappointing plays. It is kind of at the beginning of this great 2-year bull market in all of these stocks. There are a lot of companies in this sector. They are working hard to try to increase its sales in hospital equipment.

Aurora Spine (ASG-X)
June 30, 2015

One of the most disappointing plays. It is kind of at the beginning of this great 2-year bull market in all of these stocks. There are a lot of companies in this sector. They are working hard to try to increase its sales in hospital equipment.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$0.650
Owned
Yes
PAST TOP PICK
PAST TOP PICK
March 24, 2015

(Top Pick Mar 31/14, Down 70.59%) It went up and then went down. It is competing with 10 or 12 others. It will be much better later. The original run up was just speculation.

Aurora Spine (ASG-X)
March 24, 2015

(Top Pick Mar 31/14, Down 70.59%) It went up and then went down. It is competing with 10 or 12 others. It will be much better later. The original run up was just speculation.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$1.350
Owned
Yes
PAST TOP PICK
PAST TOP PICK
February 2, 2015

(A Top Pick Jan 13/14. Down 66.82%.) Had an amazing initial climb based on the clamping of the spinal vertebrae. Probably just had too much of a push. They are now down into the hard work of selling into the hospital systems in the US, which apparently have turned a bit cautious. Have 12 or 13 competitors.

Aurora Spine (ASG-X)
February 2, 2015

(A Top Pick Jan 13/14. Down 66.82%.) Had an amazing initial climb based on the clamping of the spinal vertebrae. Probably just had too much of a push. They are now down into the hard work of selling into the hospital systems in the US, which apparently have turned a bit cautious. Have 12 or 13 competitors.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$1.440
Owned
Yes
HOLD
HOLD
December 11, 2014

Have been getting clearance for their spinal devices in the US, England and most recently in Canada. They are in the build process, exhibiting patients, working hard to get into the hospitals, and have launched an additional product. Have about 12 competitors. The stock ran too far, right in the beginning. He will continue to hold.

Aurora Spine (ASG-X)
December 11, 2014

Have been getting clearance for their spinal devices in the US, England and most recently in Canada. They are in the build process, exhibiting patients, working hard to get into the hospitals, and have launched an additional product. Have about 12 competitors. The stock ran too far, right in the beginning. He will continue to hold.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$1.450
Owned
Yes
HOLD
HOLD
August 21, 2014

It went too high too fast. They are simply getting down to work now. You have to be a little patient.

Aurora Spine (ASG-X)
August 21, 2014

It went too high too fast. They are simply getting down to work now. You have to be a little patient.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$2.140
Owned
Unknown
SPECULATIVE BUY
SPECULATIVE BUY
August 6, 2014

This kind of collapsed in a mysterious way in July. Thinks it went too far, too fast. Wait for the recovery for the company to get its nose and head down and get working on the products, and selling into the US hospital space. Have new products and they are getting serious. Thinks it has now stabilized. Speculatively, it could easily double in the next 12 months.

Aurora Spine (ASG-X)
August 6, 2014

This kind of collapsed in a mysterious way in July. Thinks it went too far, too fast. Wait for the recovery for the company to get its nose and head down and get working on the products, and selling into the US hospital space. Have new products and they are getting serious. Thinks it has now stabilized. Speculatively, it could easily double in the next 12 months.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$2.400
Owned
Yes
BUY
BUY
June 4, 2014

Medical devices. This is probably one of the better corrections as it has had a phenomenal move. There is a dearth of news on the company. They have FDA approval. Things are kind of slow in hospital orders in the US at the moment. This sounds like an opportunity. A great investment for a retail investor who doesn’t have all that much money.

Aurora Spine (ASG-X)
June 4, 2014

Medical devices. This is probably one of the better corrections as it has had a phenomenal move. There is a dearth of news on the company. They have FDA approval. Things are kind of slow in hospital orders in the US at the moment. This sounds like an opportunity. A great investment for a retail investor who doesn’t have all that much money.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$2.870
Owned
Yes
TOP PICK
TOP PICK
March 31, 2014

Patented, approved technology. A Spinal fusion clamp. 50 or so operations completed.

Aurora Spine (ASG-X)
March 31, 2014

Patented, approved technology. A Spinal fusion clamp. 50 or so operations completed.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$4.590
Owned
Yes
TOP PICK
TOP PICK
January 13, 2014

Spinal repair, less invasive. He has met them, and the company is run by a man that was formerly a nurse. 55 operations to date and now it has approval from the FDA.

Aurora Spine (ASG-X)
January 13, 2014

Spinal repair, less invasive. He has met them, and the company is run by a man that was formerly a nurse. 55 operations to date and now it has approval from the FDA.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$4.340
Owned
Yes
Showing 1 to 11 of 11 entries
  • «
  • 1
  • »